MIM
RXST icon

Macroview Investment Management’s RxSight RXST Stock Holding History

Macroview Investment Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-94
Closed -$4.65K – 444
2024
Q3 		$4.65K Sell
94
-137
-59% -$7.02K ﹤0.01% 379
2024
Q2 		$13.9K Sell
231
-25
-10% -$1.43K 0.01% 203
2024
Q1 		$13.2K Sell
256
-23
-8% -$1.13K 0.01% 228
2023
Q4 		$11.3K Buy
279
+32
+13% +$939 0.01% 238
2023
Q3 		$6.89K Buy
+247
New +$7.37K 0.01% 339

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Macroview Investment Management's RXST Position: Q4 2024 in Review

Macroview Investment Management sold out of RxSight (RXST) in Q4 2024, closing a stake of 94 shares — an estimated $4.65K sold.

Macroview Investment Management first reported a position in RXST in Q3 2023 and held it in 5 quarters. The position peaked at $13.9K in Q2 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

  • Macroview Investment Management reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 94 RxSight shares in Q4 2024, an estimated $4.65K.
  • Macroview Investment Management first reported a position in RxSight in Q3 2023 and held it in 5 quarters.
  • Macroview Investment Management's RxSight position peaked at $13.9K in Q2 2024.
  • 212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.